Drug Profile
HIV vaccine (multivalent) - AlphaVax
Alternative Names: HIV (multivalent) - AlphaVax; Multi-gene HIV alphavaccine product - AlphaVaxLatest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator AlphaVax
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for phase-I development in HIV-1-infections in USA
- 07 May 2018 Phase-I clinical trials in HIV-1 infections in USA (unspecified route) (AlphaVax pipeline, May 2018)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-1-infections in USA